Because now, we've shared this molecule, just since December of last year, with 40 laboratories in the United States and 30 more in Europe -- many of them pharmaceutical companies, seeking now to enter this space, to target this rare cancer that, thankfully right now, is quite desirable to study in that industry.
因为我们现在与众分享我们的分子 就从去年12月 和美国的40家实验室， 欧洲30多家实验室， 其中很多是来自制药公司 开始进入这个领域 目标是这个罕见的癌症 有幸的是，现在这是 我们行业里比较合乎需求的